Birth Control Pill Recall

The FDA has announced a recall of the birth control pill called Mibelas 24 Fe.

Lupin Pharmaceuticals says there was a mistake with packaging.

The first four days are labeled as active pills but they're placebo, so they won't prevent pregnancy.

The lot in question is L-600-518 with an expiration of May 2018.

Baltimore, Maryland, Lupin Pharmaceuticals Inc. announced today that it has voluntarily recalled lot L600518, Exp 05/18 of Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol 1 mg/0.02 mg chewable and ferrous fumarate 75 mg).

A confirmed market complaint indicated a packaging error, where the blister was rotated 180 degrees within the wallet, reversing the weekly tablet orientation and making the lot number and expiration date no longer visible. The first four days of therapy would have had four non-hormonal placebo tablets as opposed to the active tablets.

As a result of this packaging error, oral contraceptive tablets that are taken out of sequence may place the user at  risk for contraceptive failure and unintended pregnancy. The reversing the order may not be apparent to either new users or previous users of the product, increasing the likelihood of taking the tablets out of order.

For patients in whom a pregnancy is contraindicated or in whom concomitant medication(s) may have teratogenic effects, an unintended pregnancy may cause significant adverse maternal or fetal health consequences, including death.To date there have been no reports of such adverse events.

Photo Credit: FDA

Health Clipboard

Health Clipboard

Health news and discoveries in San Diego. Marilyn Hyder hosts weekdays on KOGO AM! Read more

title

Content Goes Here